SOBECO
Drug that Quickly Reduces Alcohol Intoxication
Health Tech & Life Sciences
Non Active, Dec 2016
Company Overview
Snapshot
Founded in January 2011, SOBECO operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of biomedical products aimed at reducing alcohol intoxication.
Business overview
SOBECO is a Health Tech & Life Sciences company focused on developing biomedical products. The company's core objective is to create a drug that can rapidly eliminate the negative effects of alcohol on the body after moderate drinking, thereby addressing issues related to alcohol-related incidents. It operates within the pharmaceuticals sector, targeting the healthcare and life sciences markets.
Log in to access full profile ›Company Intelligence Q&A
- What is SOBECO's primary focus?
- SOBECO's primary focus is on developing a drug designed to quickly reduce alcohol intoxication and eliminate the negative effects of alcohol on the body after moderate drinking.
- When was SOBECO founded?
- SOBECO was founded in January 2011.
- What is the company's current funding stage?
- SOBECO is currently in the Pre-Funding stage, established in November 2011 to work on R&D, patent writing, and partnering strategies.
- What market does SOBECO target?
- SOBECO targets the healthcare and life sciences market, specifically within the pharmaceuticals sector.
- What is SOBECO's mission regarding alcohol consumption?
- SOBECO aims to reduce the number of alcohol-related car accidents and enhance the safety of alcohol use by developing a drug that mitigates the negative effects of alcohol.